Compositions and methods for inhibiting LPA expression

NZ835839APending Publication Date: 2026-08-28DICERNA PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ835839
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-09-04
Filing Date
2021-08-05
Publication Date
2026-08-28

Smart Images

  • Figure 00000135_0000
    Figure 00000135_0000
  • Figure 00000136_0000
    Figure 00000136_0000
  • Figure 00000137_0000
    Figure 00000137_0000
Patent Text Reader

Abstract

Oligonucleotides are provided herein that inhibit apolipoprotein(a) (LPA) expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and / or conditions associated with LPA expression.
Need to check novelty before this filing date? Find Prior Art